Physician profile
Ajay Parikh
NPI 1679566400
$2,030.44
in general payments reported to CMS, 2019-2025
10 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $255 · 2021: $222 · 2022: $115 · 2023: $13.11 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,379.15 | 2019-2021 | |
| Atricure, INC. | $178.37 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $111.68 | 2021 | |
| Medtronic Vascular, INC. | $106.15 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.24 | 2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $71.91 | 2022-2023 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.27 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.18 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.97 | 2019 | |
| Pfizer INC. | $14.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.